{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:04:45Z","timestamp":1778828685601,"version":"3.51.4"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100009930","name":"Basilea Pharmaceutica","doi-asserted-by":"publisher","award":["#102571"],"award-info":[{"award-number":["#102571"]}],"id":[{"id":"10.13039\/501100009930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/jac\/dkz102","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T07:12:17Z","timestamp":1550819537000},"page":"1921-1927","source":"Crossref","is-referenced-by-count":21,"title":["In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales"],"prefix":"10.1093","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-1865","authenticated-orcid":false,"given":"Patrick","family":"Schwarz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Respiratory and Critical Care Medicine, University Hospital Marburg, Marburg, Germany"},{"name":"Center for Invasive Mycoses and Antifungals, Philipps University Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra V","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Center for Invasive Mycoses and Antifungals, Philipps University Marburg, Marburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Felske-Zech","sequence":"additional","affiliation":[{"name":"Department of Legal Medicine, University Hospital Gie\u00dfen, Gie\u00dfen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-3830","authenticated-orcid":false,"given":"Eric","family":"Dannaoui","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Descartes, Facult\u00e9 de M\u00e9decine, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Unit\u00e9 de Parasitologie-Mycologie, Paris, France"},{"name":"Dynamyc Research Group (EA 7380), Paris Est Cr\u00e9teil University, Cr\u00e9teil, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"2019062107401823500_dkz102-B1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2019062107401823500_dkz102-B2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2019062107401823500_dkz102-B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2019062107401823500_dkz102-B4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"2019062107401823500_dkz102-B5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"2019062107401823500_dkz102-B6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/AAC.44.1.143-149.2000","article-title":"Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin","volume":"44","author":"Cruz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B7","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.45.11.3162-3170.2001","article-title":"Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR","volume":"45","author":"Cruz","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B8","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/JCM.43.6.2824-2829.2005","article-title":"Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species","volume":"43","author":"Sugita","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019062107401823500_dkz102-B9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22, 989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J Antibiot"},{"key":"2019062107401823500_dkz102-B10","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/AAC.00184-09","article-title":"In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes","volume":"53","author":"Dannaoui","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B11","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/AAC.48.5.1664-1669.2004","article-title":"In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B12","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.44.3.739-746.2000","article-title":"Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991\/caspofungin acetate (L-743, 873) with calcineurin inhibitors FK506 and L-685, 818 against Cryptococcus neoformans","volume":"44","author":"Del Poeta","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis","volume":"52","author":"Kontoyiannis","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/dkm493","article-title":"In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves","volume":"61","author":"Li","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/42.6.747","article-title":"Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains","volume":"42","author":"Maesaki","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B16","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.44.11.2932-2938.2000","article-title":"Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B17","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AAC.47.3.956-964.2003","article-title":"Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei","volume":"47","author":"Onyewu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.01070-07","article-title":"In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods","volume":"52","author":"Sun","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01397-07","article-title":"Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms","volume":"52","author":"Uppuluri","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jac\/dkg090","article-title":"Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species","volume":"51","author":"Kontoyiannis","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B22","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/AAC.00492-07","article-title":"Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model","volume":"51","author":"Onyewu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B23","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/AAC.48.12.4922-4925.2004","article-title":"In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/infdis\/jis767","article-title":"Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis","volume":"207","author":"Lewis","year":"2013","journal-title":"J Infect Dis"},{"key":"2019062107401823500_dkz102-B25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkq020","article-title":"In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes","volume":"65","author":"Narreddy","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B26","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/jac\/dkr297","article-title":"In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis","volume":"66","author":"Thakur","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jof4030090","article-title":"Therapy of mucormycosis","volume":"4","author":"Sipsas","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"2019062107401823500_dkz102-B28","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi\u2014Second Edition: M38","year":"2008"},{"key":"2019062107401823500_dkz102-B29","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"key":"2019062107401823500_dkz102-B30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijantimicag.2018.09.003","article-title":"An alternative strategy for combination therapy: interactions between polymyxin B and non-antibiotics","volume":"53","author":"Otto","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2019062107401823500_dkz102-B31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13693780801975576","article-title":"Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus","volume":"46","author":"Arikan","year":"2008","journal-title":"Med Mycol"},{"key":"2019062107401823500_dkz102-B32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jac\/dkn005","article-title":"In vitro activities of combinations of amphotericin B, posaconazole and four other agents against Rhizopus","volume":"61","author":"Ballester","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B33","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dks137","article-title":"In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs","volume":"67","author":"Drogari-Apiranthitou","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkw433","article-title":"Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis","volume":"72","author":"Gebremariam","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2019062107401823500_dkz102-B35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0732-8893(02)00509-6","article-title":"In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota","volume":"45","author":"Gomez-Lopez","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019062107401823500_dkz102-B36","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00595-07","article-title":"Synergistic effect of posaconazole and caspofungin against clinical zygomycetes","volume":"51","author":"Guembe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B37","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/JCM.02326-10","article-title":"Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India","volume":"49","author":"Hemashettar","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2019062107401823500_dkz102-B38","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B39","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1128\/AAC.03261-14","article-title":"In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds","volume":"58","author":"Katragkou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B40","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00492-08","article-title":"Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro","volume":"52","author":"Perkhofer","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B41","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/AAC.00628-08","article-title":"Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae","volume":"52","author":"Rodriguez","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B43","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1128\/AAC.02612-12","article-title":"Drug combinations against Mucor irregularis in vitro","volume":"57","author":"Zhang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019062107401823500_dkz102-B44","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"},{"key":"2019062107401823500_dkz102-B45","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","article-title":"Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients","volume":"23","author":"Falck","year":"2008","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/7\/1921\/28851695\/dkz102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:35:32Z","timestamp":1569976532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/7\/1921\/5424934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,4,1]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz102","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,4,1]]}}}